Aethlon Medical INC S-1 registration statements

Aethlon Medical, Inc. has filed Amendment No. 2 to its Form S-1 Registration Statement, primarily to include an updated consent from its independent registered public accounting firm.

Aethlon Medical, Inc. has filed an S-1/A registration statement detailing a proposed offering of common stock and warrants, aiming to raise capital for general corporate purposes.

Aethlon Medical, Inc. filed an S-1 registration statement for the resale of up to 2,031,024 shares of common stock underlying various warrants, primarily from a December 2025 private placement.

Aethlon Medical, Inc. filed an S-1/A registration statement for a best-efforts public offering of common stock and warrants to raise capital, while disclosing substantial doubt about its ability to continue as a going concern.

Aethlon Medical, a clinical-stage medical device company, is seeking to raise capital through a best-efforts public offering of common stock and warrants to fund operations, despite significant historical losses and substantial doubt about its ability to continue as a going concern.

Aethlon Medical launches a best-efforts offering of common stock and warrants to fund research, clinical trials, and general corporate activities.

Aethlon Medical is offering up to 5,228,758 shares of common stock and accompanying warrants in a best-efforts offering to fund research and development of its Hemopurifier device.

Aethlon Medical launches a best-efforts offering of common stock and warrants, aiming to raise capital for research, clinical trials, and general corporate purposes.

Aethlon Medical, Inc. files for a best-efforts offering of common stock and warrants, aiming to raise up to $8 million for general corporate purposes.